Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALIVE: Omega-3 PUFAs with Recanalization Therapy in Acute Large Vessel Occlusion Stroke
ChiCTR2500114317Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Guangdong Medical University
- Start
- Dec 2025
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of omega-3-acid triglycerides in ischemic stroke (2 arms), sponsored by The Affiliated Hospital of Guangdong Medical University. Primary endpoint: National Institutes of Health Stroke Scale (NIHSS) score at day 7. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
omega-3-acid triglycerides
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2500114317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114317.